C&EN, February 12, 2018
With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.
- Gonçalo Andrade, PhD, Business Development Manager
- Peter Villax, Vice President of Innovation
- Carla Vozone, Senior Director, Product Development and Licensing